Prognostic significance of α-fetoprotein in gastric adenocarcinoma

Prognostic significance of α-fetoprotein in gastric adenocarcinoma

Saved in:

Bibliographic Details
Main Authors:	Sezgin Vatansever, Merve Özer, Elvan Erdoğan
Format:	Article
Language:	English
Published:	Termedia Publishing House 2022-03-01
Series:	Gastroenterology Review
Subjects:	gastric cancer α-foetoprotein mortality.
Online Access:	https://www.termedia.pl/Prognostic-significance-of-fetoprotein-in-gastric-adenocarcinoma,41,46629,1,1.html
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Analysis of postoperative morbidity and mortality following surgery for gastric cancer. Surgeon volume as the most significant prognostic factor
by: Maciej Ciesielski, et al.
Published: (2017-09-01)

Dual-positive gastric cancer: an extremely malignant subtype of gastric cancer with high serum alpha-fetoprotein and carcinoembryonic antigen concentrations
by: Weixun Xie, et al.
Published: (2025-01-01)

SOX-9 as a prognostic marker in gastric adenocarcinoma
by: Efe Yetişgin, et al.
Published: (2025-01-01)

Metastatic gastric adenocarcinoma in prostate: A case report
by: Naru Shimizu, et al.
Published: (2025-03-01)

The Relationship Between Serum miRNAs and Surgical Prognostic Factors in Gastric Cancers
by: Çağrı Büyükkasap, et al.
Published: (2024-10-01)

ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation
by: Jiaxing Zhang, et al.
Published: (2025-02-01)

Epidemiology of gastric cancer: global trends, risk factors and prevention
by: Prashanth Rawla, et al.
Published: (2018-11-01)

Evolution of mortality for stomach cancer during the past 20 years in the US
by: Camilla Mattiuzzi, et al.
Published: (2025-01-01)

Peiminine Enhances Doxorubicin Cytotoxicity and Downregulates hsa-miR-106a-5p and hsa -miR-181a-5p in Human Gastric Adenocarcinoma Cells
by: Shirin Hedayati, et al.
Published: (2024-12-01)

Gastric Adenocarcinoma Incidentally Detected by PET/CT with PSMA Ligands
by: Cesare Michele Iacovitti, et al.
Published: (2025-01-01)

Identified VCAM1 as prognostic gene in gastric cancer by co-expression network analysis
by: Wenjuan Li, et al.
Published: (2024-12-01)

CHST1 as a prognostic-related biomarker in gastric cancer correlating with immune infiltration
by: Long Gui, et al.
Published: (2025-02-01)

The profiles of immunosuppressive microenvironment in the Lauren intestinal-type gastric adenocarcinoma
by: Qingyuan Wang, et al.
Published: (2025-02-01)

Metachronous Schnitzler’s Metastasis of Gastric Adenocarcinoma 13 Years After Curative Resection: A Case Report
by: Jun Kyeong Lim, et al.
Published: (2024-12-01)

Inflammatory burden index as a prognostic marker in patients with advanced gastric cancer treated with neoadjuvant chemotherapy and immunotherapy
by: Jiao-Bao Huang, et al.
Published: (2025-01-01)

Selection of surgical procedures and analysis of prognostic factors in patients with primary gastric tumour based on Cox regression: a SEER database analysis based on data mining
by: Cheng Xu, et al.
Published: (2021-06-01)

The importance of complete blood count parameters in the screening of gastric cancer
by: Evrim Aksoy, et al.
Published: (2019-09-01)

Endoscopic Treatment of Early-stage Large Gastric Cancer and Closure with Hand-suturing Technique
by: Fatih Aslan, et al.
Published: (2024-07-01)

The gastric microbiome altered by A4GNT deficiency in mice
by: Dawei Gong, et al.
Published: (2025-02-01)

Complications and outcomes in diffuse large B‐cell lymphoma with gastric lesions treated with R‐CHOP
by: Tomohiro Kadota, et al.
Published: (2019-03-01)

Study on the value of gastrin 17 and aldehyde dehydrogenase 1 in gastric juice for early diagnosis in gastric cancer
by: Yanfang Wang, et al.
Published: (2025-01-01)

Secondary amyloidosis with concomitant gastric GIST and gastric adenocarcinoma - A case report
by: Ankita Soni, et al.
Published: (2023-07-01)

Gastric cancer – Clinical aspects
by: J. Bornschein
Published: (2024-09-01)

The burden of Gastric Cancer and possible risk factors from 1990 to 2021, and projections until 2035: findings from the Global Burden of Disease Study 2021
by: Niping Qin, et al.
Published: (2025-01-01)

Multivariate Cox regression analysis of prognostic genes and therapeutic mechanisms of gastric cancer
by: Yangyang Xiao, et al.
Published: (2025-02-01)

Characteristics and clinical significance of immune cells in omental milky spots of patients with gastric cancer
by: Yasunobu Mano, et al.
Published: (2025-01-01)

Development and validation of a prognostic prediction model for elderly gastric cancer patients based on oxidative stress biochemical markers
by: Xing-Qi Zhang, et al.
Published: (2025-02-01)

Diagnosis and treatment of early gastric cancer: experience of one center
by: Zbigniew K. Kula, et al.
Published: (2018-02-01)

Evolution of drug therapy in patients with resectable gastric and esophageal‑gastric junction cancer
by: M. V. Sedova, et al.
Published: (2023-06-01)

Association of tumour mutation burden with prognosis and its clinical significance in stage III gastric cancer
by: Ya-Lin Han, et al.
Published: (2024-11-01)

Gastric precancerous conditions or lesions and Helicobacter pylori
by: M Areia, et al.
Published: (2024-09-01)

Development and validation of a prognostic and drug sensitivity model for gastric cancer utilizing telomere-related genes
by: Xiaoxiao Li, et al.
Published: (2025-02-01)

Robotic surgery in gastric cancer: A bibliometric analysis
by: Jinpeng Yuan, et al.
Published: (2025-02-01)

Pre-clinical study of curcumin in the treatment of gastric Cancer
by: Minghui Hao, et al.
Published: (2025-02-01)

Dynamic monocyte changes as prognostic indicators in operable gastric cancer: a retrospective cohort analysis
by: Yiwei Jiang, et al.
Published: (2025-02-01)

Gastric cancer in Ukraine: epidemiologic data and its nosological structure between 2003 and 2020
by: Yevgen O. Chernov, et al.
Published: (2024-02-01)

RETRACTED ARTICLE: Research on the efficacy of Celastrus Orbiculatus in suppressing TGF-β1-induced epithelial-mesenchymal transition by inhibiting HSP27 and TNF-α-induced NF-κB/Snail signaling pathway in human gastric adenocarcinoma
by: Yaodong Zhu, et al.
Published: (2014-11-01)

Construction of machine learning-based models for screening the high-risk patients with gastric precancerous lesions
by: Shuxian Yu, et al.
Published: (2025-01-01)

Tumor-associated-fibrosis and active collagen-CD44 axis characterize a poor-prognosis subtype of gastric cancer and contribute to tumor immunosuppression
by: Yingqi Yang, et al.
Published: (2025-01-01)

Targeted therapy and immunotherapy for gastric cancer: rational strategies, novel advancements, challenges, and future perspectives
by: Dong Luo, et al.
Published: (2025-02-01)